Youngevity International Announces Agreement for Strategic Acquisition of Legacy for Life
San Diego, California – August 25, 2016 – Youngevity International, Inc., a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels, announced today that the Company has entered into an agreement to acquire the assets of Legacy for Life, LLC a science-based, direct seller of IGY, the patented key ingredient in i26 and Legacy for Life Products. Additionally, Youngevity has entered into an Ingredient Supply Agreement to market i26 worldwide.
Steve Wallach, Youngevity, CEO stated, “We have been working on bringing Legacy for Life into the Youngevity family for quite some time. We are intrigued by the fifteen years of research and the millions of dollars that have been spent to deliver a product that can partner with a person’s immune system in a way not possible in the past. We believe i26 is a product poised to change the way we stay well. With the importance of the human intestinal flora just beginning to be recognized as a factor in both intestinal and extra-intestinal health, we are thrilled to be able to add this very special ingredient and product line to Youngevity.”
Dave Briskie, President and CFO of Youngevity said, “We believe Legacy for Life is an ideal strategic acquisition for Youngevity which fits perfectly into our global plans. Not only will we pick up strong leadership in the US, but we intend to immediately leverage Legacy for Life’s already established offices in Taiwan and Hong Kong. We believe combining these capabilities with our Singapore office opened earlier this year will accelerate our expansion plans into Asia.”
Ainslee Crum, CEO of Legacy for Life concluded, “We are extremely excited to be able to join forces with Youngevity International. We believe this acquisition will be a positive and perfect win for everyone in the Legacy for Life Family and we are excited to bring i26 to Youngevity’s growing group of distributors and customers around the world.”
Safe Harbor Statement
This release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions and includes statements regarding the These statements are based upon current beliefs, expectations and assumptions and include statements regarding the expected completion of the acquisition of the assets of Legacy for Life, LLC, the potential for the i26 products to promote healthy gut flora and healthy digestion, partner with a person’s immune system and change the way we stay well, the Legacy for Life acquisition fitting perfectly into our global plans, leveraging Legacy for Life’s office in Taiwan and Hong Kong to accelerate our expansion plans into Asia, and our continued growth . are subject to a number of risks and uncertainties, many of which are difficult to predict, including our ability to close as expected and successfully integrate the Legacy for Life acquisition, the ability of i26 products to gain greater market acceptance and continue to be shown to promote healthy gut flora and healthy digestion, our ability to accelerate our expansion plans into Asia, and the other factors described in our Report on Form 10-K for the year ended December 31, 2015 and its other filings with the Securities and Exchange Commission, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.
Image Source: LegacyForLife.com